WebDec 30, 2024 · New findings from a congressional investigation into the Food and Drug Administration and the biotech company Biogen find the FDA broke its own protocols to approve a new Alzheimer’s drug last year. WebBiogen is committed to providing continued support during these unprecedented times. Biogen Support services is here to help with starting treatment and to provide support throughout treatment with Biogen therapies. For information about Biogen initiatives in response to the COVID-19 outbreak, please visit Biogen COVID-19 Information Center.
Biogen to develop amyloid beta-targeting antibody platform
WebJun 30, 2024 · Two House committees have launched an investigation into the approval and pricing of the Alzheimer's disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm. WebJun 12, 2024 · FDA approval of Biogen's Alzheimer's drug Aduhelm has sparked a major controversy in dementia treatment. More than 6 million Americans suffer from … rick ness leese m arie
CBDistillery® launches Synergy series to expand product portfolio
WebBiogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of … We drive innovation to defeat some of the most complex and devastating diseases. … With a strong focus on difficult-to-treat diseases, our pipeline is focused on … Meet our executive leadership team. Caring deeply. Working fearlessly. Changing lives. Biogen is a leading global biotechnology company that pioneers science and … Subscribe to receive news and stories from Biogen that reflect both our dedication to … Our medicines aim to improve the well-being of people around the world. Our … Biogen Support Services 1-800-456-2255 (U.S. residents only) SMA Support … WebApr 11, 2024 · As generic competition bites for multiple sclerosis drug Tecfidera, Biogen is reportedly making ... Biogen is axing positions once again. This time, the company is reportedly targeting employees ... WebMay 3, 2024 · The company also reported lower sales of its specialty drug Spinraza, which is used to treat a rare spinal disorder in children. For the year, Biogen reaffirmed earnings guidance of between $14.25 ... rick ness leese